A Wisconsin orthopedics startup has already raised $881,668 in quest of $1 million, according to a recent regulatory filing. Flex Biomedical is developing a polymer-based synthetic viscosupplement that would serve as an alternative to hyaluronic, acid-based, injectable viscosupplements that are meant to alleviate pain and boost joint movement in patients suffering from osteoarthritis. Co-founder and […]
A Wisconsin startup is hoping that its disruptive technology will alter the landscape of osteoarthritis treatment forever. Currently, osteoarthritis, especially in the knee, is often treated with hyaluronic acid-based injectable viscosupplements that are meant to alleviate pain and boost joint movement. But Madison, Wisconsin-based Flex Biomedical has developed a polymer-based synthetic viscosupplement that co-founder and […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Flex is developing a polymer-based joint lubricant to reduce pain and increase mobility in osteoarthritis patients. It's meant to replace hyaluronic acid injection treatments that in many cases keep pain away for six months to a year, but in some cases don't work at all. They want to be in clinical trials no later than 2011.